Background
==========

Spinal cord injury (SCI) can lead to severe autonomic, sensory, and motor dysfunction \[[@b1-medscimonit-24-8878]\]. It is estimated that more than 3 million people live with spinal cord injury and its worldwide incidence is 23 to 70 individuals per million \[[@b2-medscimonit-24-8878]\]. Due to the high incidence and high disability rate of spinal cord injury, a serious burden has been placed on society and families. Spinal cord injury can be divided into primary mechanical injury and secondary injury \[[@b3-medscimonit-24-8878]\]. According to the pathogenesis and the time after injury, the secondary injury process can be divided into acute, subacute, and chronic phases \[[@b4-medscimonit-24-8878]\]. In addition, 'microenvironment imbalance' is considered to be the main cause of the poor regeneration and recovery of SCI \[[@b5-medscimonit-24-8878]\]. Microenvironmental imbalances are often accompanied by increased inhibitory factors, loss of neurons, filling of glial cells and reduction of promoting factors at different times and spaces \[[@b6-medscimonit-24-8878]\]. Multiple cells combined with different nutritional factors or scaffolds have become the focus of spinal cord injury repair \[[@b7-medscimonit-24-8878]\]. However, treatment with cells, surgery, or medication have been unable to completely cure spinal cord injuries \[[@b8-medscimonit-24-8878]\].

Conrad Waddington defined the term "epigenetics" to describe inherited changes in phenotypes without genotypic changes \[[@b9-medscimonit-24-8878],[@b10-medscimonit-24-8878]\]. At present, epigenetics usually refers to a stable genetic phenotype resulting from a chromosome change without variations in the DNA sequence \[[@b11-medscimonit-24-8878]\]. Due to the role of transcriptional and epigenetic regulations, even though mature cells start off with the same genotype, their phenotypes may quite different \[[@b12-medscimonit-24-8878]\]. In the brain of adult vertebrates, the formation of new neurons occurs in a specific population of cells. Nerve regeneration is extremely difficult under normal physiological conditions, and it is usually described as being induced after spinal cord injury \[[@b13-medscimonit-24-8878]\]. Although the exact mechanism of neural repair is not yet clear, previous studies have shown that specific cytoplasmatic factors (exosome), transcriptional factor network, and epigenetic regulators play key roles in nerve regeneration \[[@b14-medscimonit-24-8878]\].

DNA methylation is one of the most thoroughly studied epigenetic modifications \[[@b15-medscimonit-24-8878]\]. The characteristic of DNA methylation is adding a methyl group to cytosine nucleotide without changing the properties of base pairs. Due to the influence of environment or age, different DNA methylation patterns affect the expression of genes involved in crosstalk between neural activity and inflammatory pathways, further contributing to various diseases \[[@b16-medscimonit-24-8878]\]. Previous studies have confirmed that DNA methylation is associated with a variety of diseases such as cancer \[[@b17-medscimonit-24-8878]\], Alzheimer's disease \[[@b18-medscimonit-24-8878]\], and hematological diseases \[[@b19-medscimonit-24-8878]\]. DNA methyltransferases are key enzymes in the process of DNA methylation. More and more studies have shown that DNA methyltransferase plays a critical role in the early development of the central nervous system (CNS), including cognition, learning, and memory \[[@b20-medscimonit-24-8878]\]. However, the effect of DNA methylation on spinal cord injury has been unclear.

In the present study, whole-genome bisulfite sequencing (WGBS) technology was used to assess tissue before and after spinal cord transection in rats. The discovery of abnormal DNA methylation in the thoracic spinal cord might provide a new repair approach for epigenetic therapies of spinal cord injury.

Material and Methods
====================

Animals
-------

Adult female Wistar rats (approximately 230--250 g, provided by Radiation Study Institute-Animal Center, Tianjin, China, License Key: SCXK2012-0004) were used in this study. Two experimental groups were established: a sham group (n=9) and a SCI group (n=9). All animal experiments were performed according to the guidelines for laboratory animal safety and care as issued by the Ethics Committee of Tianjin Medical University General Hospital and the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978). All procedures performed in the study involving animals were consistent with the ethical standards set by the above-mentioned institutions.

Spinal cord transection
-----------------------

Adult female Wistar rats were used for spinal cord transection as described earlier \[[@b21-medscimonit-24-8878]--[@b23-medscimonit-24-8878]\]. In brief, all rats subjected to SCI were deeply anesthetized with isoflurane to minimize suffering. Following laminectomy at the T10--11 vertebral level, a 2-mm segment of spinal cord with associated spinal roots was completely removed at the T10 spinal cord level. Sham control rats also underwent laminectomy without contusion. For postoperative care, the bladder was emptied manually twice a day for a month. All rats received an intramuscular injection of penicillin (40 000 U/kg/day) for 5 days to prevent infection.

DNA methylation analysis
------------------------

DNA was extracted from the spinal cord using a DNA extraction kit (TIANamp Genomic DNA Kit, China) according to the manufacturer's instructions. Five hundred nanograms of bisulfite-converted DNA per sample were analyzed by Illumina Infinium Human Methylation 450 BeadChip array (Illumina, China). Raw data analysis and preliminary data quality control were performed with GenomeStudio software 2011.1 (Illumina, China). Specific experimental procedures for DNA methylation sequencing are shown in [Figure 1](#f1-medscimonit-24-8878){ref-type="fig"}. For further gene expression analysis, all data were imported into Cytoscape software (v3.6.1) and GraphPad Prism software (Graph Pad v6.01) for functional analysis and statistical analysis \[[@b24-medscimonit-24-8878]\]. Differentially methylated genes (DMGs) were identified (mean methylation difference ≥20, *P*\<0.001) as described earlier \[[@b25-medscimonit-24-8878]\]. Using the bioinformatics resources of DAVID 6.7 (*<https://david.ncifcrf.gov/>*), the Gene Ontology (GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of differentially methylated genes were performed \[[@b26-medscimonit-24-8878]\].

Histology and immunohistochemistry
----------------------------------

The histological evaluation was performed at 4 weeks post surgeries. The rats were anesthetized with isoflurane and transcardially perfused with 4% paraformaldehyde in PBS. Spinal cord tissue was cut into paraffin sagittal sections of 7 μm thickness. After the paraffin sections were prepared, the paraffin sections were stained with hematoxylin-eosin (Solarbio, China), as described previously \[[@b27-medscimonit-24-8878]\]. Finally, the stained sections were observed under a microscope (Nikon, Japan).

Quantitative real-time PCR
--------------------------

Total RNA was extracted from spinal cord tissues using TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions \[[@b28-medscimonit-24-8878]\]. One microgram of total RNA per sample was reverse-transcribed using a Reverse Transcription Kit (Applied Biosystems, USA). Quantitative real-time RT-PCR was performed on a LightCycler^®^ 480 Real-Time PCR System (Roche, Germany) using SYBR-Green (Thermal, USA). GAPDH acted as internal control. The primers are listed in [Table 1](#t1-medscimonit-24-8878){ref-type="table"}. All samples were analyzed in duplicate, then the average value of the duplicates was used for quantification.

Behavioral analysis
-------------------

After surgery, hindlimb function of the rats was evaluated with the Basso, Beattie, and Bresnahan (BBB) open field locomotor test \[[@b29-medscimonit-24-8878]\]. BBB scores were taken 3 days prior to injury, and once each week following SCI, for 8 weeks. BBB scores of each animal were calculated as the average of movement scores between the 2 hind limbs. Two independent researchers blind of the different experimental treatments determined the BBB scores.

Statistical analysis
--------------------

All statistical analyses were performed using the GraphPad Prism software. Data are reported as mean ± standard deviations. The BBB scores data were evaluated using 2-way analysis of variance (ANOVA). *P*\<0.05 was considered a statistically significant difference.

Results
=======

Histological and behavioral evaluation after spinal cord injury
---------------------------------------------------------------

After spinal cord injury, the loss of neuronal cell was noticeable and axons were severed. Cells and tissue morphology of the sham group were relatively complete ([Figure 2A](#f2-medscimonit-24-8878){ref-type="fig"}). Inflammatory cell infiltration, bleeding, and glial scars were observed in the SCI group ([Figure 2B](#f2-medscimonit-24-8878){ref-type="fig"}). Motor function recovery was evaluated using the BBB open field locomotor test. The BBB scores ranged from 0 (no hindlimb movement) to 21 (normal hindlimb move) according to the rating scale. After successful spinal cord injury, the BBB score of all rats in the SCI group was 0. After 8 weeks, the score of motor function of some rats in the SCI group reached 5 ([Figure 2C](#f2-medscimonit-24-8878){ref-type="fig"}).

Identification of DMGs in SCI
-----------------------------

After the whole-genome bisulfite sequencing, a total of 623 487 210 clean reads in the sham group and 623 545 728 clean reads in the SCI group were obtained, respectively. There were 1158 differentially methylated genes identified ([Table 2](#t2-medscimonit-24-8878){ref-type="table"}). Among differentially methylated genes, 50.95% were hypermethylated and 49.05% were hypomethylated. A total of 370 differentially methylated genes between the sham group and SCI group were selected (*P*\<0.05). According to screening criteria (mean methylation difference ≥20, *P*\<0.001), 96 methylated genes were selected. Among them, 50 genes were hypermethylated and 46 genes were hypomethylated ([Tables 3](#t3-medscimonit-24-8878){ref-type="table"}, [4](#t4-medscimonit-24-8878){ref-type="table"}). All of the aberrantly expressed genes are shown in a heat map in [Figure 3](#f3-medscimonit-24-8878){ref-type="fig"}.

GO enrichment analysis and KEGG pathway analysis
------------------------------------------------

The results of GO enrichment analysis are presented in [Table 5](#t5-medscimonit-24-8878){ref-type="table"}. In the biological processes (BP), the hypermethylated genes were significantly enriched in spermatogenesis, regulation of cell shape, and neurogenesis. Regarding the molecular function (MF), the hypermethylated genes were mainly enriched in plasma protein binding and metal ion binding. In the cellular component (CC), the hypermethylated genes were significantly enriched in membrane, extracellular exosome, and membrane. The biological processes enriched by the hypomethylated genes included brain development, protein phosphorylation, and response to ethanol. In molecular function, the hypomethylated genes were mainly enriched in protein binding and calcium ion binding. In the cellular component, the hypomethylated genes were enriched in cytoplasm and extracellular exosome.

KEGG pathway analysis results are shown in [Table 6](#t6-medscimonit-24-8878){ref-type="table"}. According to KEGG pathway analysis, the DMGs were significantly enriched in the Axon guidance pathway, Endocytosis pathway, T cell receptor signaling pathway, and Hippo signaling pathway.

PPI network analysis
--------------------

Protein--protein interaction (PPI) networks analysis was performed using Cytoscape software. The PPI network of hypermethylated/hypomethylated genes is shown in [Figure 4](#f4-medscimonit-24-8878){ref-type="fig"}. According to [Figure 4A](#f4-medscimonit-24-8878){ref-type="fig"}, a total of 48 nodes and 41 interaction pairs were included in this network. Some proteins involved in the Calcium signaling pathway, such as Htr7, Gna14, Adra1a, Cysltr2, Itpr3, Ppp3cc, and Slc8a1, are central nodes in this network. The top core genes were chosen: Csf2, Fars2, Synj2, Ppp3cc, Stat4, Casp8, Cysltr2, and Tiel. These genes and the number of gene cords are shown in [Figure 4B](#f4-medscimonit-24-8878){ref-type="fig"}. A total of 43 nodes and 33 interaction pairs were included in this network ([Figure 4C](#f4-medscimonit-24-8878){ref-type="fig"}). Some proteins involved in the Endocytosis pathway, such as Arfgef1, Flt1, Cyth1, Dnm3, Snx1, and Spg21, are central nodes in this network. The top core genes were chosen: Pcsk2, Dnm3, Hmgcll1, Flt1, Plcg2, RT1-Db1, Ntrk3, and Atp10a. These genes and the number of gene cords are shown in [Figure 4D](#f4-medscimonit-24-8878){ref-type="fig"}.

Genes expression validation by qRT-PCR
--------------------------------------

In addition to validating the WGBS analysis results, qRT-PCR was used to quantify parts of mRNAs of corresponding methylated genes in the SCI group compared with the sham group. Among these core genes, there were 5 differentially hypermethylated genes (Csf2, Fars2, Synj2, Ppp3cc, and Stat4) and 3 differentially hypomethylated genes (Pcsk2, Dnm3, and Hmgcll1). A search of PubMed revealed that all of these genes are involved in central nervous system repair. [Figure 5](#f5-medscimonit-24-8878){ref-type="fig"} shows that 5 mRNAs of differentially hypermethylated genes were downregulated in the SCI group compared with the sham group (*P*\<0.05), and 3 mRNAs of differentially hypomethylated genes were upregulated in the SCI group compared with the sham group (*P*\<0.05).

Discussion
==========

During the past decade, few studies have revealed the epigenetic changes that accompany the formation and development of the central nervous system \[[@b30-medscimonit-24-8878],[@b31-medscimonit-24-8878]\]. In the early stages of the development of the central nervous system, DNA methylation may play an essential role. It is reported that DNA methylation regulates the differentiation of neurons, which is closely related to adult learning, memory, and cognition \[[@b32-medscimonit-24-8878]\]. During the process of DNA methylation changes, it is easy to cause more epigenetic diseases due to other factors such as the environment. Therefore, whole-genome bisulfite sequencing of DNA methylation helps reveal epigenetic modifications underlying a variety of complex diseases.

In this study, we first established a transection model of spinal cord injury. Then, histological and motor function scores of Wistar rats before and after spinal cord injury were assessed. We further used whole-genome bisulfite sequencing to analyze epigenetic changes in rat spinal cords before and after injury. In bioinformatics analysis, approximately 96 differential DNA methylation genes were identified, including 50 hypermethylation genes and 46 hypomethylated genes. After GO enrichment analysis, KEGG signaling pathway analysis, and PPI network analysis of these significantly different DNA methylated genes, several core genes in this epigenetic change were screened out, such as Csf2, Fars2, Synj2, Ppp3cc, Stat4, Pcsk2, Dnm3, and Hmgcll1. In addition, we used qRT-PCR to verify the expression of these genes.

Bioinformatics analysis was performed on the selected hypomethylated genes. In GO analysis of biological processes, these hypomethylated genes were significantly enriched in brain development, protein phosphorylation, and response to ethanol, while in the cellular component, the hypomethylated genes were enriched in cytoplasm and extracellular exosome. These hypomethylated genes may be closely related to the formation and regeneration of the central nervous system, and epigenetic changes in these genes may lead to the proliferation and migration of nerve cells (e.g., neurons, oligodendrocytes, and astrocytes) after nerve injury. Among these genes, Dnm3 attracted our attention. Previous reports have shown that Dnm3 is an important epigenetic marker for early detection of breast cancer \[[@b33-medscimonit-24-8878]\]. There is increasing evidence that Dnm3 plays a critical role in primordial short stature, neurodevelopmental impairments, and microcephaly \[[@b34-medscimonit-24-8878]\]. In addition, Dnm3 is expressed in the brain and contributes to myelin formation, which promotes axon maturation and myelination \[[@b35-medscimonit-24-8878]--[@b36-medscimonit-24-8878]\]. This is consistent with changes in hypomethylated genes affecting axonal remodeling after spinal cord injury in rats in the present study. In KEGG analysis, these hypomethylated genes were significantly enriched in the Endocytosis pathway and Hippo signaling pathway. This may be related to the influence of Dnm3 on the coupling between the post-synaptic density scaffold and the endocytic zones \[[@b37-medscimonit-24-8878]\]. Previous studies have shown that the use of a proliferation-inducing medium containing Y-27632 (Rho/Rho-kinase pathway inhibitor) to culture neural stem cells (NSCs) can activate the Hippo signaling pathway and enhance axon regeneration of NSCs \[[@b38-medscimonit-24-8878]\], and found that inhibition of ROCK mediates neurite outgrowth in NSCs by activating the Hippo signaling pathway. This is consistent with the results of the present study. After PPI analysis of the hypomethylated genes, the top 5 core genes were Pcsk2, Dnm3, Hmgcll1, Flt1, and Plcg2.

In GO analysis, we found that the hypermethylated genes enriched in biological processes included spermatogenesis, neurogenesis, and regulation of cell shape. In molecular function, the hypermethylated genes were mainly enriched in metal ion binding and plasma protein binding. Regarding the cellular component, we found the hypermethylated genes were significantly enriched in membrane, extracellular exosome, and membrane. Csf2 is a member of the colony-stimulating factors (CSFs) family. This cytokine family includes widely known hematopoietic growth factors \[[@b39-medscimonit-24-8878],[@b40-medscimonit-24-8878]\]. Initially, colony-stimulating factor 2 was reported to play a key role in embryonic and early nervous system development \[[@b41-medscimonit-24-8878]\[. A previous study focused on long noncoding RNAs and messenger RNAs indicated that Csf2 contributes to pathogenesis in the immediate phase of spinal cord injury in adult SD rats \[[@b42-medscimonit-24-8878]\]. These results all suggest that Csf2 genes may be potential biomarkers in the central nervous system. KEGG analysis showed that these hypermethylated genes were significantly enriched in the T cell receptor signaling pathway, Axon guidance pathway, Calcium signaling pathway, Dopaminergic synapse pathway, and Taste transduction pathway. Previous research has indicated that T cell receptor signaling pathways are crucial in development of neuropathic pain following spinal cord injury \[[@b43-medscimonit-24-8878]\]. Another study demonstrated that changes in the Axon guidance pathway along with an upregulation of voltage-dependent calcium channel alpha (2) delta-1 subunit Cacna2d1, could contribute to increased mechanical sensitivity \[[@b44-medscimonit-24-8878]\]. These pathway changes are consistent with the results of our study. In addition, we performed PPI network analysis on hypermethylated genes; the top 5 core genes were Csf2, Fars2, Synj2, Ppp3cc, and Stat4.

Although this study is the first to reveal epigenetic changes after spinal cord injury in Wistar rats, there are still some limitations that need to be addressed. First, we used rodent models, and primate models and even human studies are needed. Second, the central nervous system contains the spinal cord and brain, and the structure and function of the brain are more complex than in the spinal cord, but we did not perform epigenetic studies of the brain. Third, DNA methylation is an important part of epigenetics, and after spinal cord injury, histone modification, gene silencing, and changes in genomic imprinting need to be further explored. In addition, the type of spinal cord injury should be assessed and the screening of more core genes is needed in future work. Despite these limitations, this study furthers understanding of epigenetic changes in spinal cord injury.

Conclusions
===========

The present study performed a comprehensive bioinformatics analysis; 96 differential DNA methylation genes were identified in the thoracic spinal cord tissue following transection injury compared with sham group samples. Among them, 50 genes were hypermethylated and 46 genes were hypomethylated. Moreover, the Axon guidance pathway, Endocytosis pathway, T cell receptor signaling pathway, and Hippo signaling pathway were identified and may be significant mechanisms involved. Core genes such as Csf2, Fars2, Synj2, Ppp3cc, Stat4, Pcsk2, Dnm3, and Hmgcll1 are potential new markers for more accurate diagnosis and effective therapy of spinal cord injury. These markers can be used in drug therapy to alleviate the development of neuropathic pain caused by spinal cord injury and to promote axon maturation, myelin formation, and nerve repair.
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![Concise experimental procedure for the whole-genome bisulfite sequencing.](medscimonit-24-8878-g001){#f1-medscimonit-24-8878}

![Histological observation and motor function assessment after spinal cord injury. (**A**) Hematoxylin-eosin staining of spinal cord sections in the sham group at 8 weeks after reperfusion. (**B**) Hematoxylin-eosin staining of spinal cord sections in the SCI group at 8 weeks after reperfusion. (**C**) BBB scores of Wistar rats. Values are means ±SE (\* *P*\<0.0001).](medscimonit-24-8878-g002){#f2-medscimonit-24-8878}

![Representative heat map of the top 100 differentially methylated genes. Red indicates hypermethylated genes and blue indicates hypomethylated genes.](medscimonit-24-8878-g003){#f3-medscimonit-24-8878}

![PPI network and the Core genes. (**A**) PPI network of hypermethylated genes. (**B**) Core genes of hypermethylated genes. (**C**) PPI network of hypomethylated genes. (**D**) Core genes of hypomethylated genes.](medscimonit-24-8878-g004){#f4-medscimonit-24-8878}

![Validation of the differential expression of 8 mRNAs of corresponding methylated genes identified in the WGBS in the SCI group compared with the sham group by qRT-PCR. Values are means ±SE (\* *P*\<0.05).](medscimonit-24-8878-g005){#f5-medscimonit-24-8878}

###### 

Information on primer sequences.

  Gene      Forward primer 5′ to 3′    Reverse primer 5′ to 3′    Annealing temperature (°C)
  --------- -------------------------- -------------------------- ----------------------------
  Csf2      AATGACATGCGTGCTCTGGAGAAC   TCGTCTGGTAGTGGCTGGCTATC    54
  Fars2     CCACCTGGCAGAACTTCGATAGC    GTCACGCCGATACACATCACCTAC   54
  Synj2     TCCATGTCTCGTACCATCCAGTCC   CCGTGTTGTCCAGCAGCATCC      53
  Ppp3cc    TCCGAGGCTGCTCCTACTTCTTC    AGCCAGTTGCTTGGTTCTTCCTG    54
  Stat4     CAGGACTGGAAGAAGCGGCAAC     AAGCAGTTCTGAAGCTGGTCCAAC   53
  Pcsk2     CACAGTCAACGCAACCAGGAGAG    ACCTTGGAGTCGTCGTCTCTTGG    54
  Dnm3      GTCACACCAGCCAACACCGATC     GGTGATAACGCCAATGGTCCTCAG   54
  Hmgcll1   ACTCCAGGCAGCATGAAGACAATG   TCATGGCAGTGAACAGCAAGAGC    54

###### 

Differential methylation in the spinal cord.

  Class                                                    Hypermethylated   Hypomethylated   Total
  -------------------------------------------------------- ----------------- ---------------- --------------
  Differentially methylated genes                          590               568              1158 (100%)
  DMG, *P*\<0.05, mean.meth.diff=20                        189               181              370 (31.95%)
  DMG, *P*\<0.001, mean.meth.diff=20 (remove repetition)   50                46               96 (8.29%)

###### 

Complete list of the 50 hypermethylated genes.

  Chr     Symbol      ID                         Length   Num. CpGs   DMR. p value   DMR. q value   Mean. meth. diff
  ------- ----------- -------------------------- -------- ----------- -------------- -------------- ------------------
  chr10   Fbxw11      NM_001106993_I2_introns    13       3           3.97E-13       3.71E-11       41.39596773
  chr1    Gna14       NM_001013151_I1_introns    44       3           4.18E-10       1.02E-08       39.78573567
  chr2    Chi3l3      NM_001191712_I5_introns    289      3           6.72E-07       5.21E-06       39.31869094
  chr1    Vps13a      NM_001100975_E54_exon      51       3           4.76E-10       1.07E-08       38.36766934
  chr15   Adra1a      NM_017191_I1_introns       203      4           7.06E-13       2.54E-11       38.16288829
  chr6    Frmd6       NM_001271054_I1_introns    171      3           7.03E-12       2.11E-10       37.4625921
  chr7    Palm        NM_130829_I8_introns       170      4           0.000442034    0.001304001    36.40773047
  chr6    Nubpl       NM_001185025_I4_introns    121      3           4.52E-07       6.02E-06       35.86094377
  chr17   Crem        NM_001110860_I3_introns    105      3           8.12E-05       0.000517023    35.7757685
  chr7    Fam227a     NM_001130581_I20_introns   61       3           0.000174069    0.000641881    35.64110942
  chr10   Fstl4       NM_001107000_I4_introns    15       3           1.34E-05       0.000156783    34.86382548
  chr2    Col11a1     NM_013117_I49_introns      226      3           1.04E-05       5.08E-05       34.8266253
  chr10   Neurl1b     NM_001142652_I4_introns    80       7           9.05E-06       0.000120934    34.13727909
  chr13   Plxna2      NM_001105988_I3_introns    219      3           3.78E-05       0.000184147    33.8264037
  chr12   Fry         NM_001170398_I63_introns   55       4           8.19E-08       3.44E-06       33.49560871
  chr10   Snx29       NM_001109526_I7_introns    6        4           2.56E-05       0.000217367    33.28848981
  chr10   Litaf       NM_001105735_I1_introns    54       5           6.91E-10       2.59E-08       33.03121583
  chr1    Slc22a3     NM_019230_I1_introns       28       3           3.77E-09       7.37E-08       33.00571733
  chr18   Fbn2        NM_031826_I10_introns      202      4           1.04E-13       5.10E-12       32.59773088
  chr17   Susd3       NM_001107341_I1_introns    228      4           5.87E-05       0.000435361    31.38181808
  chr15   Cysltr2     NR_131894_I4_introns       390      4           0.000284111    0.000601647    30.97831867
  chr15   Fndc3a      NM_001107278_I21_introns   516      5           0.000898606    0.001586244    30.17566608
  chr2    Fat4        NM_001191705_I1_introns    449      5           2.40E-05       0.000101298    30.11072466
  chr1    Syt3        NM_019122_I5_introns       71       3           2.07E-07       2.64E-06       29.85324558
  chr18   Ldlrad4     NM_001271365_I1_introns    85       3           0.000175281    0.00071573     29.56178745
  chr19   Cdh13       NM_138889_I4_introns       116      10          7.40E-08       3.11E-06       29.18274327
  chr10   Asic2       NM_001034014_I6_introns    11       4           0.000718251    0.002857722    28.85755303
  chr1    Il4r        NM_133380_I1_introns       111      3           0.000835518    0.002523782    26.43736728
  chr8    Kirrel3     NM_001048215_I1_introns    146      3           0.000935696    0.00519023     26.2257812
  chr1    Ezr         NM_019357_I12_introns      86       13          3.17E-07       3.31E-06       25.69879184
  chr2    Bank1       NM_001047918_I10_introns   696      6           0.000248188    0.000607409    25.27410866
  chr15   Ppp3cc      NM_134367_I8_introns       628      3           1.49E-09       1.79E-08       25.22411799
  chr10   Cpped1      NM_001013963_I3_introns    45       4           0.000373298    0.001745166    25.13311283
  chr1    Ust         NM_001108458_I5_introns    138      3           2.52E-11       1.23E-09       25.06445554
  chr9    Stat4       NM_001012226_I10_introns   125      3           6.22E-06       4.71E-05       24.88762551
  chr10   Rab11fip4   NM_001107023_I3_introns    29       3           0.000195025    0.001022057    24.47716696
  chr10   Dexi        NM_001109026_I1_introns    51       4           2.70E-09       6.48E-08       24.31882587
  chr17   Mpp7        NM_001100575_I12_introns   128      3           0.000163608    0.000880968    24.29724306
  chr10   Zc3h7a      NM_001108262_E23_exon      50       3           0.00033137     0.001621921    23.86498374
  chr6    Slc8a1      NM_001270773_I6_introns    151      5           0.000633381    0.001794639    23.70245762
  chr3    Tspan18     NM_001107750_I8_introns    41       3           0.000144543    0.00100661     23.25712602
  chr1    Arntl       NM_024362_I2_introns       43       3           3.93E-14       2.88E-12       22.86236695
  chr15   Ppp2r2a     NM_053999_I7_introns       205      15          7.78E-09       5.60E-08       22.86049685
  chr2    Arsb        NM_033443_I4_introns       1282     21          5.69E-14       2.65E-12       22.42210761
  chr5    Slco5a1     NM_001107898_I8_introns    154      4           0.000156566    0.0007552      22.36790713
  chr8    Arhgap20    NM_213629_I9_introns       59       5           0.000990502    0.00519023     21.72558987
  chr6    Arid4a      NM_001108029_I5_introns    100      4           0.00047549     0.00142647     21.4264141
  chr1    Syt17       NM_138849_I3_introns       56       3           1.50E-05       6.87E-05       21.27406378
  chr1    Synm        NM_001134858_I2_introns    104      5           9.91E-07       8.06E-06       21.19753403
  chr6    Rtn1        NM_053865_I49_introns      141      3           4.75E-05       0.000195013    21.15397951

###### 

Complete list of the 46 hypomethylated genes.

  Chr     Symbol       ID                          Length   Num. CpGs   DMR. p value   DMR. q value   Mean. meth. diff
  ------- ------------ --------------------------- -------- ----------- -------------- -------------- ------------------
  chr8    Snx1         NM_053411_I8_introns        16       3           0.000178924    0.001674221    39.23422802
  chr10   Nubp1        NM_001009619_I9_introns     51       3           2.77E-09       6.48E-08       38.19511889
  chr19   Atp6v0d1     NM_001011927_I7_introns     27       3           8.97E-07       1.88E-05       37.45568608
  chr8    Bckdhb       NM_019267_I3_introns        91       6           4.56E-11       1.99E-09       36.09637024
  chr6    Prkch        NM_031085_I10_introns       130      4           5.03E-06       3.02E-05       35.65709264
  chr13   Hmcn1        NM_001271292_I106_introns   168      3           4.14E-08       4.04E-07       35.19645258
  chr1    Zp2          NM_031150_E10_exon          79       4           0.00049086     0.001580462    33.48819301
  chr2    Ptpn22       NM_001106460_I13_introns    70       3           5.71E-05       0.000202829    32.53343885
  chr2    Skiv2l2      NM_001034093_I2_introns     95       4           3.00E-08       3.49E-07       31.5071179
  chr1    Tulp2        NM_001012168_I1_introns     110      6           9.46E-07       7.92E-06       31.18947695
  chr12   Fry          NM_001170398_I14_introns    19       3           2.19E-05       0.000288601    30.41340002
  chr1    Slco3a1      NM_177481_I8_introns        85       3           0.000528807    0.001684136    30.13666411
  chr1    Atp10a       NM_001141935_I3_introns     27       6           1.03E-06       8.14E-06       30.06814676
  chr1    Prkg1        NM_001105731_I15_introns    70       5           0.000356284    0.001186265    28.94112061
  chr4    Grm7         NM_031040_I7_introns        192      3           0.000245364    0.001003763    28.53745911
  chr10   Carhsp1      NM_152790_I2_introns        102      5           2.26E-05       0.000211468    28.25784027
  chr2    Noct         NM_138526_I1_introns        17       3           0.000373085    0.000889665    28.10593157
  chr15   Gpc5         NM_001107285_I2_introns     205      4           2.72E-09       2.44E-08       27.84298084
  chr16   Nrg1         NM_001271130_I1_introns     272      4           0.000226123    0.000621838    27.46776641
  chr7    Dmc1         NM_001130567_I6_introns     134      3           0.000623225    0.001671375    27.18046865
  chr8    Tex264       NM_001007665_I3_introns     13       4           4.67E-12       3.06E-10       26.94493645
  chr1    Oprm1        NR_027877_I3_introns        167      4           5.98E-05       0.000236705    26.39509712
  chr1    Ntrk3        NM_001270655_I14_introns    19       4           0.000915163    0.00273615     26.34513213
  chr6    Psma3l       NM_001004094_I5_introns     128      3           1.84E-06       1.57E-05       26.13483738
  chr6    Psma3        NM_017280_I5_introns        128      3           1.84E-06       1.57E-05       26.13483738
  chr7    Cpq          NM_031640_I8_introns        174      5           0.000464492    0.001305002    25.03471249
  chr1    Tpd52l1      NM_001044295_I1_introns     43       4           2.22E-06       1.41E-05       24.99670494
  chr1    RGD1307603   NM_001134508_E3_exon        35       6           6.18E-05       0.000241568    24.98945466
  chr19   Gfod2        NM_001107421_I2_introns     100      9           4.56E-06       6.38E-05       24.49436882
  chr10   Cyth1        NM_053910_E12_exon          56       6           2.55E-05       0.000217367    24.45542274
  chr13   Gpatch2      NM_001011909_I1_introns     258      3           9.48E-05       0.000369638    23.92339964
  chr9    Myo1b        NM_053986_I3_introns        136      6           8.64E-05       0.000351935    23.4475614
  chr18   Ldlrad4      NM_001271365_I5_introns     494      14          5.50E-07       5.39E-06       23.43565697
  chr6    Frmd6        NM_001271054_I1_introns     304      4           0.000701646    0.001871057    23.28083922
  chr1    Plpp4        NM_001191631_I5_introns     86       3           1.05E-05       5.31E-05       23.22492261
  chr1    Gpr139       NM_001024241_I1_introns     38       3           0.00021821     0.000752181    22.95290692
  chr10   Ccdc40       NM_001134688_I1_introns     38       4           4.16E-05       0.000338144    22.84818656
  chr13   Cntnap5b     NM_001047873_I1_introns     329      3           1.10E-05       6.16E-05       22.56555396
  chr19   Zfp612       NM_001107428_I3_introns     169      5           0.000905479    0.004444048    22.51841655
  chr8    Dpp8         NM_001108159_I13_introns    120      13          0.000326038    0.002512407    22.4358468
  chr9    Sphkap       NM_001127492_I13_introns    199      4           0.000143173    0.000508033    21.12261507
  chr1    Ipcef1       NM_001170799_I1_introns     88       4           0.000961996    0.002847121    20.82969003
  chr5    Slco5a1      NM_001107898_I1_introns     62       3           8.67E-05       0.000473983    20.47392161
  chr4    Prickle2     NM_001107876_I1_introns     181      7           0.000537784    0.001861562    20.45460701
  chr1    Hddc2        NM_001108460_I2_introns     61       4           2.61E-05       0.000112648    20.32430339
  chr9    Kcnh8        NM_145095_I9_introns        302      5           3.28E-05       0.000150472    20.01509207

###### 

Gene ontology analysis of aberrantly methylated-differentially expressed genes in spinal cord injury.

  Category           Term                                                Count   \%     P value
  ------------------ --------------------------------------------------- ------- ------ -------------
  GOTERM_BP_DIRECT   GO:0007283 spermatogenesis                          6       5      0.083899175
  GOTERM_BP_DIRECT   GO:0008360 regulation of cell shape                 5       4.1    0.007915904
  GOTERM_BP_DIRECT   GO:0022008 neurogenesis                             4       3.3    0.00873703
  GOTERM_BP_DIRECT   GO:0006470 protein dephosphorylation                4       3.3    0.032688039
  GOTERM_BP_DIRECT   GO:0006897 endocytosis                              4       3.3    0.046516317
  GOTERM_CC_DIRECT   GO:0005886\~plasma membrane                         33      0.2    0.035034848
  GOTERM_CC_DIRECT   GO:0070062\~extracellular exosome                   27      0.1    0.005859253
  GOTERM_CC_DIRECT   GO:0016020\~membrane                                22      0.1    0.018591495
  GOTERM_CC_DIRECT   GO:0005887\~integral component of plasma membrane   14      0.1    0.003864181
  GOTERM_CC_DIRECT   GO:0048471\~perinuclear region of cytoplasm         13      0.1    0.000430891
  GOTERM_MF_DIRECT   GO:0005515\~protein binding                         19      0.1    0.005508607
  GOTERM_MF_DIRECT   GO:0046872\~metal ion binding                       15      0.1    0.032965821
  GOTERM_MF_DIRECT   GO:0005509\~calcium ion binding                     12      0.1    0.002804787
  GOTERM_BP_DIRECT   GO:0007420\~brain development                       8       6.1    0.00348475
  GOTERM_BP_DIRECT   GO:0006468\~protein phosphorylation                 8       6.1    0.043342319
  GOTERM_BP_DIRECT   GO:0045471\~response to ethanol                     6       4.6    0.008263832
  GOTERM_BP_DIRECT   GO:0007399\~nervous system development              6       4.6    0.009359172
  GOTERM_BP_DIRECT   GO:0007613\~memory                                  5       3.8    0.002955411
  GOTERM_CC_DIRECT   GO:0005737\~cytoplasm                               46      35.1   0.023089945
  GOTERM_CC_DIRECT   GO:0070062\~extracellular exosome                   34      26     0.00016196
  GOTERM_CC_DIRECT   GO:0016020\~membrane                                21      16     0.084368826
  GOTERM_CC_DIRECT   GO:0005829\~cytosol                                 18      13.7   0.031630643
  GOTERM_CC_DIRECT   GO:0005887\~integral component of plasma membrane   15      11.5   0.003637411
  GOTERM_MF_DIRECT   GO:0005515\~protein binding                         22      16.8   0.001727352
  GOTERM_MF_DIRECT   GO:0005509\~calcium ion binding                     10      7.6    0.042887314
  GOTERM_MF_DIRECT   GO:0042803\~protein homodimerization activity       10      7.6    0.088758008
  GOTERM_MF_DIRECT   GO:0030165\~PDZ domain binding                      4       3.1    0.043421165
  GOTERM_MF_DIRECT   GO:0005516\~calmodulin binding                      4       3.1    0.08759155

###### 

KEGG pathway analysis of aberrantly methylated-differentially expressed genes in spinal cord injury.

  Pathway name                        Gene num   P-value       Genes
  ----------------------------------- ---------- ------------- -----------------------------------------------------
  Hypermethylation                                             
  Calcium signaling pathway           7          0.001367652   Htr7, Gna14, Adra1a, Cysltr2, Itpr3, Ppp3cc, Slc8a1
  Endocytosis pathway                 6          0.041783996   Acap1, Ehd4, Rab11fip4, Sh3kbp1, Smurf1, Dnm3
  T cell receptor signaling pathway   4          0.020396716   Csf2, Ctla4, Ppp3cc, Vav2
  Axon guidance                       4          0.053653812   Dpysl2, Plxna2, Ppp3cc, Robo2
  Dopaminergic synapse                4          0.054679627   Arntl, Itpr3, Ppp2r2a, Ppp3cc
  Taste transduction                  3          0.053663995   Asic2, Itpr3, Trpm5
  Hypomethylation                                              
  Endocytosis pathway                 6          0.041783996   Arfgef1, Flt1, Cyth1, Dnm3, Snx1, Spg21
  Hippo signaling pathway             4          0.082043834   Frmd6, Bmp5, Ctnna2, Dlg2
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